BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Why Are People Injecting Themselves with Peptides? The New Yorker FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157: Experimental Peptide Creates Risk for Athletes